Senior Clinical Lecturer in Addiction Psychiatry, University of Birmingham, Queen Elizabeth Psychiatric Hospital, Mindelsohn Way, Edgbaston, Birmingham B15 2QZ (tel: 0121 678 2372; fax: 0121 678 2351; e-mail: e.j.day{at}bham.ac.uk)
medical student, University of Birmingham Medical School
Consultant Addiction Psychiatrist, Birmingham
|
|
|---|
A pilot study was set up to compare a symptom-triggered front-loading detoxification technique with the usual fixed dosage method. A group of 23 in-patients with alcohol dependence were randomised to receive either the intervention technique using diazepam or the standard chlordiazepoxide taper over 10 days.
RESULTS
The intervention group received a mean dosage of 74 mg diazepam (equivalent to 222 mg chlordiazepoxide) compared with 700 mg chlordiazepoxide in those receiving usual treatment. There was no statistical difference in the severity of alcohol withdrawal symptoms in the two groups, and the intervention group were slightly more satisfied with their treatment than the group undergoing the usual detoxification treatment. Feedback from the nursing staff was positive towards the new approach but highlighted some potential problems for its wider implementation.
CLINICAL IMPLICATIONS
It was possible to use a simple randomised trial design to introduce a new technique for alcohol detoxification to a specialist unit. Symptom-triggered front-loading detoxification using diazepam was as effective as a standard taper technique in terms of withdrawal severity reduction, and was acceptable to both patients and staff. This is potentially a useful technique for busy acute psychiatric wards.
|
|
|---|
A further disadvantage of fixed dosage regimens is the length of time that they take. In cases in which the expected severity of alcohol withdrawal symptoms merits admission to hospital, it is not uncommon for the medication taper to take 510 days. An alternative is the use of a front-loading approach, whereby diazepam is administered at intervals of 12 hours until the patient is asymptomatic (Heinala et al, 1990). Such an approach is refined by using a symptom severity rating scale such as the Clinical Institute Withdrawal Assessment for Alcohol Revised version (CIWAAr; Sullivan et al, 1989) to assess the severity of withdrawal symptoms, the results of which dictate the amount of benzodiazepine prescribed. Such regimens may counter many of the problems with traditional fixed dosage techniques highlighted above, with the added bonus of standardised regular monitoring of patients. Furthermore, a number of studies suggest that front-loading regimens use less medication and have a shorter duration, as well as rein-forcing the fact that many cases of alcohol withdrawal can be managed without medication at all (Sellers et al, 1983; Wartenberg et al, 1990; Saitz et al, 1994; Wasilewski et al, 1996; Silpakit et al, 1999; Reoux & Miller, 2000).
Although front-loading detoxification techniques have been reported throughout the world, no clinical trial evidence could be found from a UK centre. There are few reports of randomised controlled trials, and most studies have involved only male patients. Furthermore, it has been usual to exclude patients with a past history of seizures, even though there is other evidence to suggest that this technique is safe in this patient group (Devenyi & Harrison, 1985). This is significant in the in-patient setting, as a past history of alcohol withdrawal seizures is often a reason for choosing a hospital rather than a home detoxification process. Few of the studies reported any evaluation of patient or staff views about the process.
As a way of introducing this technique in a unit that had previously only ever used fixed dosage chlordiazepoxide schedules without symptom monitoring, we devised a randomised controlled trial to compare the new technique with standard practice. It was decided to use diazepam because of its long half-life, and so the use of a symptom-triggered regimen within the first 24 hours of the detoxification led to therapeutic concentrations of the drug being maintained for over 72 hours. Chlordiazepoxide also has a long half-life, but a regimen using diazepam had previously been shown to be safe and effective by another UK centre (Williams, 2001).
|
|
|---|
All patients meeting ICD10 criteria for alcohol dependence (World Health Organization, 1992) and requiring inpatient detoxification were considered for randomisation during the 4-month pilot phase. People dependent on substances other than alcohol, or with current severe liver impairment or other major physical illness were excluded, and those unable or unwilling to give informed consent to enter the study were given treatment as usual. All patients attended a pre-admission group meeting during which the study was explained to them and an information leaflet was distributed. On arrival at the unit all patients were assessed with the CIWAAr and were invited to join the study. If the patient gave informed consent the researcher conducted a short structured interview and administered the Severity of Alcohol Dependence Questionnaire (SADQ; Stockwell et al, 1983). The researcher then telephoned a remote randomisation service and the patient was allocated to either symptom-triggered front-loading detoxification or usual treatment. The admitting doctor then completed a full medical assessment, physical examination and blood tests. The study was approved by the local research ethics committee.
The main outcome measures were the amount of medication used in each treatment group, the duration of the detoxification period (defined as the time between the administration of the first and last medication) and the development of any adverse events. Other outcomes of interest were the level of patient satisfaction with symptom control during the detoxification period, and the views of the nursing staff administering the medication. All data analysis was carried out using the Statistical Package for the Social Sciences, version 10.0. Continuous variables that were normally distributed were compared using a t-test, and non-parametric continuous data were analysed using the MannWhitney U-test.
Intervention
All qualified nursing staff working on the in-patient unit attended a
training session on how to use the CIWAAr, at which an introductory
lecture was followed by a series of video recordings of patients at various
stages of alcohol withdrawal. The staff were asked to rate these cases using
the CIWAAr, and the results were discussed and compared with a gold
standard rating. The staff then practised rating patients admitted to the unit
prior to the start of the trial, and the results were discussed during the
weekly ward review.
Participants in the intervention group were assessed every 90 minutes using the CIWAAr, with each assessment taking approximately 10 minutes. Those scoring 11 or more received 20 mg of diazepam, whereas those with a score of 10 or less received no medication. The process was discontinued when the patient scored 10 or less on two consecutive occasions, after which no further medication was administered. Participants in the control group received 30 mg of chlordiazepoxide every 6 hours on the first day, with the dose tapering to zero according to a defined regimen over a 10-day period. Nursing staff were also able to dispense up to an additional 20 mg of chlordiazepoxide every 6 hours if they judged that the patient required it. The CIWAAr was used to assess all patients twice daily prior to the administration of medication for the first 10 days of the period of admission.
|
|
|---|
Detoxification process
A total of 23 participants were randomised: 11 to the intervention and 12
to treatment as usual. The characteristics of the two groups at baseline
assessment are shown in Table
1, with the gender mix the only difference reaching statistical
significance. Nine of the sample had well-documented evidence of previous
seizures related to alcohol withdrawal, and the mean SADQ score of the whole
sample (40.4) suggested severe alcohol dependence
(Stockwell et al,
1983). All 23 participants completed the full detoxification
process, and no one left the unit prematurely. The intervention group received
a mean dose of 74 mg of diazepam (equivalent to 222 mg chlordiazepoxide;
Bazire, 2000), compared with
700 mg of chlordiazepoxide in the control group (P<0.001). The
mean length of the detoxification period (as defined by administration of
medication) was 8.2 hours, compared with 242 hours in the control group
(P<0.001). However, despite these differences, there was little
difference in the severity of alcohol withdrawal between the two groups
throughout the 10 days studied (Fig.
1). Comparison of the two groups at each time point using a
MannWhitney U-test confirmed the null hypothesis.
|
View this table: [in a new window] | Table 1. Characteristics of the two treatment groups at baseline assessment |
![]() View larger version (7K): [in a new window] |
Fig. 1. Mean daily score on the Clinical Institute Withdrawal Assessment for
Alcohol Revised scale (CIWAAr) for patients undergoing
symptom-triggered front-loading detoxification ( ) compared with the
usual fixed dosage regimen ( ).
|
Only one patient in the study had any significant complications during the detoxification: this was a 39-year-old woman in the intervention group who was observed to have a generalised tonicclonic seizure during the evening of the first day of admission to the unit. At this point the level of severity of the patients withdrawal symptoms had been measured every 90 minutes and no symptom of alcohol withdrawal had been noted (CIWAAr score <5). On more detailed questioning the patient admitted to a history of heavy zopiclone use which had stopped abruptly 2 days prior to admission, and furthermore she had experienced epileptic seizures during periods of abstinence from alcohol in the past.
Patient satisfaction
At the end of the detoxification period (10 days after admission to the
unit) participants were asked to complete a Patient Satisfaction Questionnaire
anonymously. The participants rated the number of days out of the past 10 that
they had been troubled by 10 different withdrawal symptoms, giving a maximum
score of 100. The intervention group reported a lower median level of adverse
symptoms than did the group receiving the traditional detoxification (14.0
v. 29.5, P=0.267). In addition, the participants rated their
satisfaction with the staff, the medication and the detoxification process as
a whole on a scale of 1 to 10. Despite the shorter period of administration of
medication in the intervention group, their mean satisfaction rating was
slightly higher than that of the control group (28.0 v. 27.3,
P=0.152).
Nursing staff
Five of the six members of the nursing staff directly involved with the
care of patients in the study were interviewed to determine their opinions
about the use of symptom-triggered front-loading detoxification and its
results. Only one member of staff had been aware of the front-loading
detoxification technique prior to the start of the study. All the staff felt
that the technique gave the patients better symptom control, and they were
positive about the reduced duration of detoxification and the lower doses of
medication used. Participants were also noted to be less sedated throughout
the detoxification period, and were able to engage in psychological group work
at an earlier stage than with the traditional approach. The technique was felt
to be empowering for nursing staff, giving them more direct control over the
care of their patients. Many of the problems anticipated by the nursing staff
did not arise, but a need for ongoing training was highlighted and some
problems with low staffing levels during the trial period were also
exposed.
|
|
|---|
Front-loading detoxification techniques appear to yield potentially significant benefits in terms of bed occupancy. All patients in this study were allowed to complete the full 3-week in-patient period, as this was the duration of admission promised when they were initially placed on the waiting list for treatment. However, the reduced length of the medication period with this technique allows the option of a much shorter admission period, or less cognitive impairment for patients entering the relapse prevention group programme also available in the unit. Such techniques might be well suited to other services such as acute medical units (Lange-Asschenfeldt et al, 2003), where an initial investment in training might be rewarded by shorter durations of admission.
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||